Skip to main content
OpenTrials

Clinical trial condition

Retroviridae Infections

Explore clinical trials studying Retroviridae Infections. Study availability and eligibility vary by location and protocol.

5,663 public trials 308 recruiting studies
Refine in advanced search Browse all conditions

Retroviridae Infections trial results

Completed

Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults

NCT02915016

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
  • Fenway Health (FH) CRS Boston, Massachusetts, United States
  • Columbia P&S CRS New York, United States
View all 17 locations
View Trial Details
Completed

Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up

NCT03275350

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chemically-Induced Disorders, +20 more
Locations
  • Tarzana Treatment Centers Tarzana, California, United States
  • Jackson Memorial Hospital Miami, Florida, United States
  • Ruth M. Rothstein CORE Center Chicago, Illinois, United States
  • University of Kentucky Bluegrass Care Clinic Lexington, Kentucky, United States
View Trial Details
Completed

HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) Vaccine Study

NCT03560258

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Ucsf Hiv/Aids Crs San Francisco, California, United States
  • Northwestern University CRS Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

Evaluating the Safety and Immunogenicity of Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV Vaccines, Given Individually or Co-administered, in Healthy, HIV-1-Uninfected Adults

NCT03409276

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • Fenway Health (FH) CRS Boston, Massachusetts, United States
  • University of Rochester Vaccines to Prevent HIV Infection CRS Rochester, New York, United States
View Trial Details
Completed

Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)

NCT02519777

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • UCSD Antiviral Research Center CRS San Diego, California, United States
  • Harbor-UCLA CRS Torrance, California, United States
  • Whitman-Walker Health CRS Washington D.C., District of Columbia, United States
View all 30 locations
View Trial Details
Completed

An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials

NCT03337906

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • Bridge HIV CRS San Francisco, California, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • UIC Project WISH CRS Chicago, Illinois, United States
View all 21 locations
View Trial Details
Completed

Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection

NCT03403569

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou, Fujian, China
  • The Eighth People's Hospital of Guangzhou Guangzhou, Guangdong, China
  • The Fourth Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China
  • The Sixth People's Hospital of Zhengzhou Zhengzhou, Henan, China
View Trial Details

Related conditions